{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-061371","form_type":"8-K","ticker":"SCLX","cik":"0001820190","company_name":"Scilex Holding Co","filed_at":"2026-02-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.338413+00:00","generated_at":"2026-05-16T01:31:15.350504+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Scilex issues warrant to Oramed for 100,000 shares at $20.00 in exchange for payment deferral","bullets":["Warrant for 100,000 shares at $20.00 issued to Oramed Pharmaceuticals for deferring an amortization payment originally due Oct 1, 2025.","Deferred payment was made in November 2025; warrant is immediately exercisable and expires Dec 13, 2029.","Exercise price subject to anti-dilution adjustments with a floor of $8.22; beneficial ownership limit set at 4.99%.","Company commits to file a resale registration statement for the underlying shares within 30 days or by March 31, 2026.","Warrant agreement includes most-favored-nations clause for six months and standard change-of-control repurchase right."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-061371","json":"https://secwatch.observer/filing/0001193125-26-061371.json","markdown":"https://secwatch.observer/filing/0001193125-26-061371.md","text":"https://secwatch.observer/filing/0001193125-26-061371.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1820190/000119312526061371/0001193125-26-061371-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1820190/000119312526061371/sclx-20260219.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T01:31:15.350504+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"629d4b12b6515c382d742a35961869a5b8fa3304","claim":"Scilex Holding Co entered into Warrant Agreement with Oramed Pharmaceuticals Inc. (effective 2026-02-19).","evidence_excerpt":"On February 19, 2026, Scilex Holding Company (the “ Company ”) entered into a Warrant Agreement (the “ Warrant Agreement ”) with Oramed Pharmaceuticals Inc. (“ Oramed ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1820190/000119312526061371/0001193125-26-061371-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Counterparty","value":"Oramed Pharmaceuticals Inc."},{"label":"Effective","value":"2026-02-19"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}